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As the infectious agent causing human adult T cell leukemia (ATL), the HTLV-1 
virus spreads in vivo primarily by cell-to-cell transmission. However, the factors that 
determine its transmission efficiency are not fully understood. The viral genome 
encodes the HTLV-1 bZIP factor (HBZ) which is expressed in all ATL cases and is 
known to promote T cell proliferation. In this study, we investigated the hypothesis that 
HBZ also influences the survival of T cells. Through analyzing the transcriptional 
profile of HBZ-expressing cells, we learned that HBZ suppressed transcription of the 
proapoptotic gene Bim (Bcl2l11) and that HBZ-expressing cells were resistant to 
activation-induced apoptosis. Mechanistic investigations into how HBZ suppresses Bim 
expression revealed that HBZ perturbs the localization and function of FoxO3a, a 
critical transcriptional activator of the genes encoding Bim and also Fas ligand (FasL). 
By interacting with FoxO3a, HBZ not only attenuated DNA binding by FoxO3a but 
also sequestered the inactive form of FoxO3a in the nucleus. In a similar manner, HBZ 
also inhibited FasL transcription induced by T cell activation. Further study of ATL 
cells identified other Bim perturbations by HBZ, including at the level of epigenetic 
alteration, histone modification in the promoter region of the Bim gene. Collectively, 
our results indicated that HBZ impairs transcription of the Bim and FasL genes by 
disrupting FoxO3a function, broadening understanding of how HBZ acts to promote 





   HTLV-1 is estimated to infect 10-20 million people in the world (1). This virus 
causes not only a neoplastic disease of CD4+ T cells, ATL, but also chronic 
inflammatory diseases of the central nervous system, lung, or skin (2). HTLV-1 can be 
transmitted efficiently in a cell-to-cell fashion (3, 4), while free virus shows poor 
infectivity (5, 6), and virions are not detected in infected individuals. To increase the 
number of infected cells and facilitate transmission, HTLV-1 increases its copy number 
primarily by triggering the proliferation of infected cells -- replicating within the host 
genome instead of undergoing viral replication (7, 8). Thus, HTLV-1 promotes 
proliferation and suppresses apoptosis of infected cells via complex interactions of viral 
proteins with host factors.  
   Among the viral genes encoded in HTLV-1, the tax gene has been extensively 
studied. Tax can activate various signal pathways like NF-κB, AP-1, and SRF (9). 
However, Tax expression is frequently undetectable in ATL cases. Importantly, the 
nonsense mutations in the tax gene are often observed in not only ATL cases but also 
infected cells of asymptomatic HTLV-1 carriers (10). These findings suggest that other 
mechanisms suppress the apoptosis of HTLV-1 infected cells in the absence of Tax 
expression (2). We have reported that the HBZ gene is expressed in all ATL cases (11). 
Furthermore, HBZ promotes the proliferation of T-cells and induces development of 
T-cell lymphomas and inflammatory diseases in transgenic mice (12). Therefore, we 
speculated that HBZ might also influence apoptosis.  
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   There are two major pathways for apoptosis: the extrinsic and intrinsic apoptotic 
pathways, which are mediated by Fas and Bim respectively (13). ATL cells are known 
to express high levels of Fas antigen, and are susceptible to Fas-mediated signaling (14). 
However, Fas ligand expression is suppressed in ATL cells by silencing of the early 
growth response 3 (EGR3) gene transcription, a phenomenon which enables ATL cells 
to escape activation-induced cell death (15). In addition, Tax increases expression of 
c-FLIP, which confers resistance to Fas-mediated apoptosis (16, 17). Furthermore, 
activation of NF-κB by Tax also enables HTLV-1 infected cells to be resistant to 
apoptosis (18). To date, the effects of HTLV-1 infection on Bim-mediated apoptosis 
remain unknown.  
   In this study, we analyzed transcriptional changes induced by HBZ expression in T 
cells, and found that transcription of a proapoptotic gene, Bim, was hindered by HBZ. 
This suppression led to decreased activation-induced cell death. We found that HBZ 
suppressed Bim transcription by targeting FoxO3a, a critical transcription factor for the 
Bim and FasL gene. In some ATL cell lines and ATL cases, the Bim gene transcription 
was also silenced by epigenetic mechanisms, but this phenomenon appeared to be 
secondary to HBZ-mediated suppression of transcription. Thus, it is suggested that HBZ 
suppresses both intrinsic and extrinsic apoptotic pathways and contributes to the 
proliferation of ATL cells.  
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Materials and Methods 
 
Cell lines and clinical samples  
HTLV-1 immortalized cell lines (MT-4), ATL cell lines (ED, TL-Om1, and MT-1), 
T cell lines not infected with HTLV-1 (Jurkat, SupT1, and CCRF-CEM) were cultured 
in RPMI 1640 medium supplemented with 10% fetal bovine serum (FBS) and 
antibiotics at 37°C under a 5% CO2 atmosphere. Jurkat cells stably expressing spliced 
form of HBZ (sHBZ), Jurkat-HBZ ,were maintained as described previously (19). To 
construct CCRF-CEM cells stably expressing HBZ, CEM-HBZ, the coding sequence of 
HBZ was subcloned into pME18Sneo vector and then the expression vector or its empty 
vector were transfected into CCRF-CEM cells by using Neon (Invitrogen) according to 
the manufacturer’s instructions. Stable transfectants were selected in G418 (1mg / ml). 
293T cells were cultured in Dulbecco modified Eagle medium supplemented with 10% 
FBS and antibiotics and when 293FT cells were cultured, 500 µg/mL G418 was added. 
Fas blocking antibody was purchased from Alexis.  
   This study was conducted according to the principles expressed in the Declaration 
of Helsinki. The study was approved by the Institutional Review Board of Kyoto 
University (G204). All patients provided written informed consent for the collection of 
samples and subsequent analysis.  
 
Plasmid constructs  
Wild-type form of FoxO3a was generated by PCR amplification using Jurkat cDNA 
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library and constitutively active form of FoxO3a (FoxO3aAAA) was also generated by 
PCR amplification with mutated primers	 (20). These PCR fragments were then 
subcloned into pCMV-Tag2B vector and pIRES-hrGFP-1a (Stratagene). The vectors 
encoding the myc-His-tagged form of HBZ and its mutants used in this study have been 
described previously (19, 21).  We modified pLKO.1-EGFP vector for delivery of 
anti-FoxO3 short hairpin RNAs to Jurkat, Jurkat-control and Jurkat-HBZ. shRNA 
sequence used was 5’- GCACAACCTGTCCTGCATAG -3’. The 6xDBE-Luc construct 
that contains six FOXO-binding sites known as DAF-16 binding elements (DBEs) was 
kindly provided by Dr. Furuyama (Kagawa Prefectural University of Health Sciences) 
and the backbone of this vector was pGL3-basic (Promega) (22).  
 
Luciferase assay 
Jurkat cells were transfected with 0.2 µg/well of luciferase reporter plasmid, 1 
ng/well of Renilla luciferase control vector (phRL-TK), 0.2 µg/well of FoxO3aAAA 
expression plasmid or its empty vector and 0.6 µg/well of HBZ expression plasmid or 
its empty vector with caspase inhibitor Z-VAD-FMK (MBL). Plasmids were transfected 
using Neon (Invitrogen) according to the manufacturer’s instructions. After 24 hours, 
cells were collected and luciferase activities were measured using the Dual-Luciferase 
Reporter Assay (Promega). Relative luciferase activity was calculated as the ratio of 
firefly to Renilla luciferase activity. Three independent experiments, each with triplicate 
transfections, were performed and typical results are shown. 
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Microarray analysis  
Jurkat-control and Jurkat-HBZ were stimulated with phorbol myristate acetate 
(PMA) (50 ng/ml) and ionomycin (1 µg/ml) for 9 hrs. After the stimulation, cells were 
collected and total RNA was isolated using Trizol Reagent (Invitrogen) according to the 
manufacturer’s instructions. We then digested DNA using deoxyribonuclease I 
(Invitrogen) and cleaned up RNA using RNeasy Mini Kit (Qiagen) according to the 
manufacturer’s instructions. We then synthesized cDNA and performed microarray 
processing according to the GeneChip Expression Analysis Technical Manual 
(Affymetrix). All data were analyzed by using GeneSpring GX (Agilent Technologies). 
The microarray data related to this paper have been submitted to the Gene Expression 
Omnibus under the accession number GSE48029. 
 
Immunofluorescence analysis 
293FT cells were transfected with expression vectors using Lipofectamine LTX 
(Invitrogen) or TransIT (TAKARA). Twenty-four hours after transfection, cells were 
re-seeded on the poly-L-lysine coated glass (Matsunami-glass) or poly-D-lysine 
(SIGMA) coated glass. Twenty-four hours after the re-seeding, cells were fixed with 4% 
paraformaldehyde for 15 min and permeabilized with 0.2% Triton X-100 for 15min, 
and blocked by incubation in 5% BSA/PBS for 30 min. For immunostaining, the cells 
were incubated with anti-Foxo3a, anti-p-Foxo3a (Cell Signaling technology), 
Cy3-conjugated anti-c-Myc (SIGMA) or biotinylated anti-FLAG (SIGMA) antibodies 
for 1h or in case of observation of endogenous expression, cells were incubated 
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overnight at 4°C. Primary antibodies were visualized by incubating the cells with 
AlexaFluor 488-conjugated goat anti-rabbit IgG antibody (Invitrogen) or Alexa Fluor 
488 conjugated streptavidin (Invitrogen). Nuclei were stained and mounted with 
ProLong Gold antifade reagent with DAPI (Invitrogen). To concentrate non-adherent 
cells onto a microscope slide, Cytofuge (Statspin) was used. Fixation and blocking were 
performed as described above.  
 
Assessment of apoptosis  
Apoptotic cells were routinely identified by Annexin V-APC (eBioscience) or PE or 
FITC (BioVision) staining according to the manufacturer’s instructions and analyzed 
with a flow cytometer (BD FACSCanto II, BD Biosciences). Data files were analyzed 
by using FlowJo software (Treestar).  
 
Real-time PCR  
Total RNA was isolated for the analysis using Trizol reagent. RNA was treated with 
DNase I to eliminate the genomic DNA. Reverse transcription was performed using 
random primer and SuperScript III reverse transcriptase (Invitrogen). CD25-CD4+ cells 
from healthy donor were obtained by using human CD4 T Lymphocyte enrichment kit 
(BD Pharmingen). Then cells were stimulated with PMA/Io for 9 hrs and RNA was 
isolated and reverse transcription were performed as described above. cDNA products 
were analyzed by real-time PCR using the Taqman Universal PCR Master Mix (PE 
Applied Biosystems) or Fast Start Universal SYBR Green master (Roche) and Applied 
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Biosystems StepOnePlus real-time PCR system according to the manufacturer’s 
instructions. Specific primers and Taqman probes for the Bim gene, FasL gene and 
GAPDH internal control gene were purchased from Applied Biosystems. Primer 
sequences for the HBZ gene and GAPDH gene used for the evaluation of the knock 
down efficiency in MT-1 cells are described previously (11, 23). Primer sequences for 
the HBZ gene used for another experiment to evaluate the HBZ expression in 
Jurkat-HBZ, MT-1, TL-Om1, and ED cells were 5’- 
ATGGCGGCCTCAGGGCTGTT-3’ and 5’- GCGGCTTTCCTCTTCTAAGG-3’. 
Primer sequences for the FoxO3a gene used were 5’- 
ACAAACGGCTCACTCTGTCCCAG -3’ and 5’- 
AGCTCTTGCCAGTTCCCTCATTCTG -3’. All amplifications were conducted in 
triplicates. The relative quantification was calculated according to the method described 
in Applied Biosystems ABI prism 7700 SDS User Bulletin #2.  
 
Chromatin immunoprecipitation (ChIP) analysis  
Chromatin immunoprecipitation (ChIP) assay was performed according to the 
protocol recommended by Millipore. Cells were fixed with 1% formaldehyde for 10 
minutes at room temperature, washed twice with ice-cold PBS, treated with SDS-lysis 
buffer [1% SDS, 50 mM EDTA and 200 mM Tris-HCl] for 10 minutes on ice and then 
sonicated. Thereafter, the DNA/protein complexes were immunoprecipitated with 
antibodies specific for acetylated-Histone H3, acetylated-Histone H4, 
dimethylated-Histone H3 (Lys4), RNA polymerase II clone CTD4H8 (Millipore), 
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trimethylated-Histone H3 (Lys27), anti-trimethyl-Histone H3 (Lys9) antibodies (Cell 
Signaling technology), or normal rabbit IgG (Santa Cruz technology) overnight at 4°C . 
Immune complexes were collected with salmon sperm DNA-protein A and G Sepharose 
slurry, washed, and eluted with freshly prepared elution buffer (1% SDS, 100 mM 
NaHCO3). Protein-DNA complexes were de-crosslinked at 65°C for 4 hours. DNA was 
purified and subjected to real-time PCR for quantification of the target fragments. 
Sequences for the primer set are described previously (24, 25). For the evaluation of 
binding of FoxO3a to the FOXO-binding sites, 293T cells were transfected with the 5 
µg of 6xDBE-Luc construct, 5 µg of FoxO3aAAA expression plasmid together with or 
without 5 µg of HBZ plasmid using TransIT in 10-cm dishes. Anti-Flag (SIGMA) 
antibody was used for the immunoprecipitation. Primers used were 
5’-AGTGCAGGTGCCAGAACATT-3’ and 5’-GCCTTATGCAGTTGCTCTCC-3’ 
which were constructed inside of the pGL3-basic vector. For the evaluation of the DNA 
binding capacity of FoxO3a with or without HBZ, expression vectors for the HA-tagged 
FoxO3a and Flag-tagged HBZ were transiently cotransfected into 293T cells using the 
TransIT reagent. 24 hours after the transfection, cells were collected and chromatin 
immunoprecipitation assay was performed as described above. For the 
immunoprecipitation, anti-HA (SIGMA) antibody was used. Primers used for Bim gene 
promoter were 5’- CCACCACTTGATTCTTGCAG-3’ and 5’- 
TCCAGCGCTAGTCTTCCTTC-3’ which were constructed to contain the 
FOXO-binding sequence located in intron1. Primers used for FasL gene promoter were 
5’- ACGATAGCACCACTGCACTCC -3’ and 5’- GGCTGCAAACCAGTGGAAC 
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-3’which were also constructed to contain the three FOXO-binding sequences. 
Individual PCRs were carried out in triplicate to control for PCR variation and mean 
Ct values were collected. Fold difference of the antibody-bound fraction (IP) versus a 
fixed amount of input (In) was calculated as  𝐼𝑃 𝐼𝑛 = 2!∆∆!! = 2!(!!   !" !!! !" ) 
Then, the fold difference value for a target antibody (t) was subtracted by the 
nonspecific value derived from mouse or rabbit IgG (t0) ; 𝐼𝑃 𝐼𝑛 ! − 𝐼𝑃 𝐼𝑛 !! . 
 
Bisulfite genomic sequencing 
Sodium bisulfite treatment of genomic DNA was performed as described previously 
(26). DNA regions were amplified using bisulfite-treated genomic DNA by nested PCR. 
To amplify promoter region (promoter 1) of Bim, primers used in the first PCR were 
5’-TTTAGAGGGAGGAGAGTTTAAAG-3’ and 
5’-CCCTACAACCCAACTCTAACTA-3’. Primers for the second PCR were 
5’-AGGGTATAGTGAGAGCGTAGG-3’ and 5’-CAACTCTAACTAACGACCCC-3’. 
For promoter 2 primers used in the first PCR were 5’- 
GTGTGATTGTTTTTTGAGGG-3’ and 5’- AAAATACCCCCAAACAAAATAC-3’. 
Primers for the second PCR were 5’- GCGGATTTAGTTGTAGATTTTG-3’ and 5’- 
ACTCTTTACCCAAAACAAACTTC-3’. PCR products were purified, cloned into 
pGEM-T Easy vector (Promega), and sequenced using the ABI PRISM 3130 genetic 
analyzer. For CpG methylation analysis, web-based bisulfite sequencing analysis tool 
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called QUMA (quantification tool for methylation analysis) was used (27). 
 
Coimmunoprecipitation assay, analysis of the p-FoxO3a localization and 
immunoblotting 
Expression vectors for the relevant genes were transiently cotransfected into 293T 
cells using the TransIT reagent. 48 hours later, cells were collected and 
coimmunoprecipitation assays were performed as described previously (28). For the 
analysis of the p-FoxO3a localization, nuclear and cytoplasmic proteins were extracted 
using Nuclear Complex Co-IP Kit (Active motif). The proteins were subjected to 
SDS-PAGE analysis followed by immunoblotting with various antibodies. Antibodies 
used were anti-p-FoxO3a, anti-α-tublin (SIGMA), anti-Flag, anti-HA (SIGMA), and 
anti- His (MBL). 
 
Lentiviral vector construction and transfection of the recombinant lentivirus 
Lentiviral vector expressing shRNA against HBZ was constructed and recombinant 
lentivirus was infected as described previously (11). When > 90% of cells expressed 





The Bim gene transcription is suppressed in HBZ-expressing Jurkat and 
CCRF-CEM cells  
To determine the effects of HBZ on gene expression, we first performed microarray 
analysis. Jurkat cells with or without expression of spliced form of HBZ (Jurkat-HBZ 
and Jurkat-control, respectively) were stimulated with PMA and ionomycin (Io) for 9 
hrs. Gene expression profiles were then analyzed by DNA microarray. Table 1 shows 
the apoptosis-associated genes that were down-regulated or up-regulated in stimulated 
Jurkat-HBZ cells. Transcription of the Bim gene was prominently down-regulated in 
HBZ-expressing Jurkat cells. To confirm the effect of HBZ on the Bim gene expression, 
we evaluated Bim mRNA levels in Jurkat-control and Jurkat-HBZ cells with or without 
PMA/Io stimulation using real-time PCR. As reported in the previous studies showing 
that treatment by PMA/Io or other stimulators induced Bim expression (29, 30), the Bim 
mRNA level of stimulated Jurkat-control cells was three-times higher than that of 
unstimulated cells, but that of Jurkat-HBZ cells did not change after stimulation (Figure 
1A). Similarly, increased Bim transcription by stimulation was also inhibited by HBZ in 
CCRF-CEM cells (Figure 1A).  
 
HBZ inhibits apoptosis 
It has been reported that Bim plays an important role in activation induced cell death 
and T cell homeostasis (31). Since the above data demonstrated that HBZ inhibits 
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stimulation-induced Bim expression, we next investigated whether HBZ inhibits 
apoptosis in response to PMA/Io stimulation. To test this, Jurkat-control and 
Jurkat-HBZ were each incubated with or without PMA/Io for 9 hours, and then 
apoptosis was measured using Annexin V. The percentages of apoptotic cells in 
Jurkat-control and Jurkat-HBZ were 40.2 % and 15 % respectively, indicating that HBZ 
suppressed activation-induced apoptosis (Figure 1B). We also treated cells with 
doxorubicin and found that HBZ slightly inhibited doxorubicin-induced apoptosis 
(Supplementary Fig. S1). Fas-mediated apoptotic pathway might be involved in 
anti-apoptotic effect by HBZ. In order to assess the effect of Fas-mediated signaling on 
the activation-induced apoptosis, cells were also treated with or without Fas blocking 
antibody (0.5 µg/ml) 30 min before the PMA/Io stimulation. The percentage of 
apoptotic cells without Fas blocking antibody in Jurkat-control and Jurkat-HBZ were 
36.9 % and 22.4 %, respectively. When cells were treated with Fas blocking antibody, 
the percentage of apoptotic cells reduced and those were 24 % and 13.2 % in 
Jurkat-control and Jurkat-HBZ, respectively (Figure 1C). Thus, Fas blocking antibody 
partially inhibited apoptosis in Jurkat-HBZ, which indicates that Fas-mediated signals 
are also implicated in activation-induced cell death. Indeed, we found that the 
transcription level of FasL was suppressed in stimulated Jurkat-HBZ and CEM-HBZ 
cells compared with Jurkat-control and CEM-control cells (Figure 1D), suggesting that 
down-regulation of FasL by HBZ was also associated with inhibition of apoptosis.   
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               
HBZ suppresses Bim expression through attenuation of FoxO3a 
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   We analyzed how HBZ suppresses the expression of Bim and FasL. It has been 
reported that a Forkhead factor, FoxO3a, and p73 are important for the transcription of 
Bim and FasL (32, 33). FoxO3a and other FOXO family members are phosphorylated 
by protein kinases such as Akt or SGK on highly conserved serine and threonine 
residues (especially Thr32, Ser253, Ser315 in FoxO3a), resulting in impaired DNA 
binding activity and increased binding to the chaperone protein, 14-3-3 (20, 34, 35). 
Newly formed 14-3-3-FOXO complexes are then exported from the nucleus, thereby 
inhibiting FOXO-dependent transcription of key target genes such as Bim, FasL and 
TRAIL (36).  
   First, we investigated whether FoxO3a is implicated for the activation induced cell 
death. As shown in supplementary Fig. S2, the knockdown of FoxO3a resulted in the 
decreased apoptotic rate in Jurkat-control cells (p < 0.05). Furthermore, inhibition of 
Foxo3a did not influence activation-induced cell death in Jurkat-HBZ cells, suggesting 
that inhibitory effect of HBZ on Foxo3a function. To investigate whether HBZ affects 
FoxO3a function, Jurkat cells were transiently transfected with a plasmid expressing 
FoxO3aAAA, the constitutive active mutant of FoxO3a, which is no longer 
phosphorylated by Akt and is localized in the nucleus. The FoxO3aAAA was expressed 
together with hrGFP using an internal ribosome entry site (IRES) 
(FoxO3aAAA-IREShrGFP). Jurkat cells were transiently transfected with full-length 
HBZ or its mutants. HBZ has 3 domains, an activation domain (AD), a central domain 
(CD), and a basic leucine zipper domain (bZIP) (12). In this study the deletion mutants 
(HBZ-ΔAD, HBZ- ΔbZIP, and HBZ-ΔCD) were used. The percentage of FoxO3aAAA 
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induced apoptotic cells in the absence of HBZ was 69.6 % while it was suppressed by 
HBZ (40.6 %, p < 0.001) (Figure 2A). We also found that an HBZ mutant without 
activation domain lacks the activity to inhibit FoxO3aAAA-induced apoptosis (Figure 
2A), indicating the significance of activation domain in suppression of FoxO3a 
mediated apoptosis. It has been reported that LXXLL motif in FoxO3a binds to its 
coactivator CBP/p300 (37). Similarly, HBZ has LXXLL-like motifs located in the 
NH2-terminal region, which bind to KIX domain of CBP/p300 (38). We speculated that 
the LXXLL-like motifs of HBZ might affect FoxO3aAAA function through KIX 
domain of CBP/p300. An HBZ mutant, which has substitutions in 27th and 28th 
residues (LL to AA) of LXXLL-like motif, lack the activity to suppress FoxO3aAAA 
mediated apoptosis (Figure 2B), indicating that LXXLL-like motif of HBZ is critical for 
suppression of FoxO3a mediated apoptosis.  
   Next, we analyzed the effect of HBZ on a FoxO3a responsive reporter. As shown in 
Figure 2C, HBZ suppressed FoxO3a mediated transcriptional activity (p < 0.01). In 
order to check whether HBZ inhibits DNA binding of FoxO3a, 293T cells were 
transiently transfected with FoxO3aAAA and FoxO3a reporter, 6xDBE-Luc, together 
with or without HBZ. The interaction of FoxO3aAAA to FOXO-binding sites was 
analyzed by ChIP assay. As shown in Figure 2D, the interaction of FoxO3aAAA to the 
FOXO-binding sites was interfered by HBZ, suggesting that HBZ inhibits 
FoxO3a-mediated apoptosis through suppression of the DNA binding of FoxO3a. In 
order to clarify the mechanism of HBZ-mediated FoxO3a inhibition, we examined 
interaction between HBZ and FoxO3a by the immunoprecipitation assay. It showed that 
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HBZ interacted with FoxO3a (Figure 2E, F). Experiments with FoxO3a deletion mutant 
revealed that HBZ interacted with the forkhead domain (FH) of FoxO3a (Figure 2E). 
Analysis using HBZ deletion mutants showed that the central domain of HBZ interacted 
with FoxO3a (Figure 2F).  
 
HBZ inhibits nuclear export of phosphorylated form of FoxO3a 
Next we investigated the effect of HBZ on FoxO3a localization by confocal 
microscopy. We co-transfected 293FT cells with a plasmid expressing human wild-type 
FoxO3a (FoxO3aWT) protein and an HBZ-expressing plasmid. Consistent with 
previous reports, FoxO3a remained mainly in cytoplasm when cells were co-transfected 
with empty vector (Figure 3A) (20, 34). However, when it was expressed along with 
HBZ, FoxO3a was localized in both nucleus and cytoplasm (Figure 3A). To determine 
whether mislocalized FoxO3a is phosphorylated (pFoxO3a) or not, we used 
anti-pFoxO3a antibody. Figure 3B and 3C demonstrated that nuclear-localized FoxO3a 
was phosphorylated in HBZ expressing cells. Thereafter, we analyzed the localization 
of endogenous FoxO3a in HeLa and an ATL cell line, MT-1. Although pFoxO3a was 
localized widely both in cytoplasm and nucleus in HeLa cells, most pFoxO3a was 
localized in the nucleus in MT-1 (Figure 3D), suggesting that endogenous HBZ inhibits 
the extranuclear translocation of pFoxO3a in this cell line. From the study of crystal 
structure of the human FoxO3a-DBD/DNA complex, it has been reported that 
phosphorylation at Ser253 causes a decrease on the DNA binding ability (39). 
Abnormal localization of phosphorylated FoxO3a by HBZ might interfere the function 
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of unphosphorylated FoxO3a in the nucleus. The abnormal localization of pFoxO3a 
prompted us to investigate whether HBZ bound to 14-3-3 along with FoxO3a, since 
14-3-3 is a chaperon protein involved in nuclear-cytoplasm shuttling of FOXO family. 
As shown in Figure 3E, HBZ, FoxO3a and 14-3-3 form a ternary complex. However, 
the binding of FoxO3a and 14-3-3 was not affected by HBZ (result of IP with anti-Flag 
Ab and detected with anti-HA Ab).  
   As another possible mechanism for down-regulation of Bim and FasL, we compared 
the transcription level of p73 in Jurkat cells with and without HBZ expression. 
Activation of HBZ expressing cells reduced transcription of p73, but the expression 
level of p73 was variable among ATL cell lines (Supplementary Fig. S3A, B). We 
conclude that p73 is not responsible for suppression of Bim expression in ATL cells.  
 
Bim expression is suppressed in both ATL cell lines and ATL cases 
HBZ has been shown to suppress Bim expression through two different mechanisms 
as revealed in this study. To analyze Bim expression in ATL cells, we studied Bim 
mRNA levels in non-ATL cell lines and ATL cell lines with or without PMA/Io 
stimulation, and found that the Bim gene transcript was up-regulated in Jurkat and 
CCRF-CEM cells, but not in SupT1 after activation. However, Bim transcripts were not 
increased in all stimulated ATL cell lines (Figure 4A). The Bim gene transcript was also 
down-regulated in primary ATL cells (Figure 4B) compared with resting PBMCs and 
PHA stimulated T cells. We also stimulated primary ATL cells and normal CD4+ T 
cells with PMA/Io. The Bim gene transcription was quite low in primary ATL sample 
 19 
compared with normal CD4+ T cells even though cells were stimulated with PMA/Io 
(Figure 4C). In order to confirm HBZ expression in representative ATL cell lines, we 
quantified the level of the HBZ mRNA transcription in Jurkat-HBZ, CEM-HBZ, MT-1, 
ED and TL-Om1 by real-time PCR and confirmed that HBZ is expressed in these ATL 
cell lines (Supplementary Fig. S4). A microarray data obtained from Gene Expression 
Omnibus (GEO), shows that both Bim and FasL transcription levels are lower in ATL 
cases than healthy donors (accession number: GSE33615, Supplementary Fig. S5), 
supporting our data that Bim expression was suppressed in ATL cells.  
   
Bim expression is silenced by epigenetic mechanisms 
Since the Bim gene transcription was severely suppressed in ATL cells, we 
investigated the epigenetic status (DNA methylation and histone modification) of the 
promoter region of the Bim gene in ATL cells. A previous study showed that the 0.8 kb 
region immediately upstream of exon 1 contains the important elements for the control 
of Bim expression (promoter 1). The Bim promoter does not contain a TATA or CAAT 
box and has the characteristics of a 'TATA-less' promoter (40). Additionally, the 
alternative promoter has been reported to exist in intron 1 (promoter 2) (41, 42). These 
two promoter regions are highly GC-rich and contain the binding sites for several 
transcription factors including FoxO3a. To determine whether CpG sites in these Bim 
gene promoter regions are methylated in ATL cell lines, their methylation status was 
analyzed by bisulfite-mediated methylcytosine mapping (Supplementary Fig. S6A, B). 
The promoter 1 of Bim was hypermethylated in two ATL cell lines (ED and TL-Om1), 
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and ATL case 1 while this region was not so methylated in MT-1 cells and two ATL 
cases. On the other hand, the promoter 2 was heavily methylated in two ATL cell lines 
(TL-Om1 and MT-1) and ATL case 1 and partially methylated in Jurkat cells 
(Supplementary Fig. S6B). These results suggest that in some cases, heavily methylated 
CpG sites of promoter 1 and 2 are associated with silencing of Bim transcription but 
these methylations can not account for suppressed Bim expression in all ATL cell lines 
and ATL cases.  
   Therefore, we next focused on the histone modification in the promoter region of 
Bim. It is well known that deacetylation of the histones are also common features of 
cancer, which results in transcriptional silencing of tumor suppressor genes (43). First, 
we analyzed the histone H3 and H4 acetylation and H3K4 trimethylation, which are all 
permissive marks (44), in promoter 1 of Jurkat, MT-1, and TL-Om1 cells. Contrary to 
our speculation, neither H3, H4 acetylation nor H3K4 trimethylation did not differ 
between MT-1 and Jurkat cells (Supplementary Fig. S7). We next analyzed the histone 
modification status in promoter 2. As shown in Figure 5A, MT-1 and TL-Om1 cells 
exhibited decreased level of histone H3 acetylation and H3K4 trimethylation but not 
histone H4 acetylation. Since methylation of DNA is often preceded by dimethylation 
of H3K9 or trimethylation of H3K27 (both repressive marks) in oncogenesis (44), we 
asked whether there were differences in these epigenetic chromatin marks on the Bim 
gene promoter in ATL cell lines. TL-Om1 cells exhibited upregulated level of H3K9 
dimethylation and H3K27 trimethylation compared to Jurkat cells (Figure 5B, C) while 
MT-1 exhibited a little upregulated level of H3K27 trimethylation (Figure 5C) in the 
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promoter 2. These data suggest that histone modifications of promoter 2 are critical for 
the suppressed Bim gene transcription. We also performed ChIP analysis using 
anti-RNA polymerase II antibody (Figure 5D) and revealed that Pol II binding was 
decreased in MT-1 and TL-Om1 cells, confirming suppressed transcription of the Bim 
gene. To further investigate the mechanisms involved in FoxO3a-mediated Bim gene 
transcription in the promoter 2, we transfected HA-tagged FoxO3a expression vector 
together with or without a HBZ expression vector into 293T cells and 
immunoprecipitated with anti-HA antibody. Then the DNA binding capacity of FoxO3a 
was quantified by real-time PCR. Figure 5E shows that HBZ attenuated the DNA 
binding capacity of FoxO3a in the promoter 2 of Bim (i) and FasL promoter (ii), 
suggesting that the suppressed binding of FoxO3a to the promoter regions leads to 
inhibition of the Bim and FasL genes transcription by HBZ.  
   Next we treated MT-1 cells with trichostatin A (TSA), a cell-permeable chemical 
inhibitor of class I/II HDACs. Treatment of TSA resulted in a clear up-regulation of 
acetylation of histone H3 (Figure 5F) followed by Bim expression both at the mRNA 
(Figure 5G) and protein levels (Figure 5H), indicating that histone modification is 
associated with suppressed Bim transcription in MT-1. We also performed ChIP assay 
using Jurkat-control and Jurkat-HBZ cells, which were stimulated with PMA and 
ionomycin for 9h, and found that acetylation of histone H3 decreased in Jurkat-HBZ 
cells (Figure 5I), suggesting that HBZ is implicated in histone deacetylation in T-cells. 
To verify whether HBZ inhibits transcription of the Bim gene, we suppressed the HBZ 
gene transcription by shRNA as reported previously (11). Efficiencies of lentivirus 
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vector transduction, which were determined by EGFP expression, were 90.5 % and 
90.3 % for control MT-1 cells and HBZ-knockdown MT-1 cells, respectively. 
Suppressed HBZ expression led to increased the Bim gene transcription (Figure 5J, K), 




   Human immunodeficiency virus type 1 (HIV-1) replicates vigorously, and the 
generated virus infects target cells in vivo. Unlike HIV-1, HTLV-1 induces proliferation 
to increase the number of infected cells, since this virus is transmitted primarily by 
cell-to-cell contact (5). Therefore, HTLV-1-encoded proteins promote proliferation of 
infected cells and inhibit their apoptosis, resulting in an increased number of infected 
cells in vivo (2). In this study, we show that HBZ inhibits both the intrinsic and extrinsic 
apoptotic pathways via targeting FoxO3a, which leads to suppressed transcriptions of 
Bim and FasL. We demonstrated two mechanisms for perturbation of FoxO3a by HBZ; 
interaction of HBZ with FoxO3a and interference of nuclear export of phosphorylated 
FoxO3a. HBZ suppresses DNA binding ability of active form of FoxO3a through 
interaction between central domain of HBZ and FH domain of FoxO3a. In addition, 
LXXLL-like motif of HBZ is implicated in inhibition of FoxO3a mediated apoptosis, 
suggesting that HBZ interferes interaction of CBP/p300 and FoxO3a. Furthermore, 
HBZ retains inactive form of FoxO3a in the nucleus through interaction with 14-3-3, 
leading to transcriptional repression of the target genes. Interestingly, accumulation of 
phosphorylated form of FoxO3a in the nucleus has been observed in HIV 
Vpr-expressing cells, which might be implicated in HIV-mediated resistance against 
insulin (28). Thus, FoxO3a is a target of both human retroviruses.  
   In this study, we showed that central domain of HBZ interacts with FoxO3a while 
LXXLL-like motif in activation domain of HBZ is responsible for suppressed apoptosis. 
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LXXLL-like motif of HBZ has been reported to interact with KIX domain of p300 (38). 
The central domain of HBZ interacts with the FH domain of FoxO3a, which binds to 
the target sequence (35). This is mechanism how HBZ inhibits DNA binding of FoxO3a. 
However, inhibitory effect of HBZ on apoptosis largely depends on LXXLL-like motif 
of activation domain (Figure 2A and B). FoxO3a is also reported to interact with KIX 
domain of CBP/p300 (37). FH domain of FoxO3a intramolecularly interacts with its 
conserved regions (CR) 3, and binding of FH to DNA releases CR3, allowing it to bind 
KIX of CBP/p300 (45). These findings suggest that HBZ interferes the complex 
interaction between FoxO3a and CBP/p300, which is likely important to induce 
apoptosis.  
   It has been reported that Bim has a tumor suppressor function in various cancers. 
Hemizygous loss of the Bim gene promoted development of B-cell leukemia in 
Myc-transgenic mice in which c-myc expression was driven by the immunoglobulin 
gene intron-enhancer (46). Insulin-like growth factor 1 (IGF-1), an important growth 
factor for myeloma cells, has been reported to suppress Bim expression by epigenetic 
and posttranslational mechanisms (25). In Epstein-Barr virus infected B cells Bim 
transcription is silenced by DNA methylation of the Bim gene promoter (47). Thus, 
impaired expression of Bim is associated with the various cancers including the 
virus-related malignancies. FoxO3a is also a target of oncogenesis. BCR-ABL induces 
phosphorylation of FoxO3a, which leads to suppressed expression of Bim in Ph1+ 
chronic myelogenous leukemia cells (32). In breast cancer, IκB kinase interacts with, 
phosphorylates FoxO3a, which causes proteolysis of FoxO3a (48). In this study, we 
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revealed that HBZ hinders nuclear export of phosphorylated FoxO3a, and impairs 
function of FoxO3a likely through interaction of FoxO3a and p300. Thus, suppressed 
Bim and FasL expression through inhibition of FoxO3a by HBZ is a new mechanism 
for oncogenesis.  
   Besides of FoxO3a perturbation by HBZ, we also have identified the epigenetic 
aberrations in the promoter region of the Bim gene in ATL cells, and found that Bim 
expression is suppressed by DNA methylation and histone modification. ATL cell lines 
exhibited upregulated level of H3K27 trimethylation in the promoter regions of Bim. It 
has been reported that enhancer of zeste (EZH) 2, a methyltransferase and component of 
the polycomb repressive complex 2 (PRC2), expression is increased in ATL cell lines 
(42). Since EZH2 plays an essential role in the epigenetic maintenance of H3K27 
trimethylation, upregulated H3K27 trimethylation of the Bim gene promoter might be 
associated with increased expression of EZH2 in ATL cells. In addition, HBZ seems to 
be associated with histone deacetylation in MT-1 cells. According to the previous 
studies, it is known that both HBZ and FoxO3a bind to the histone acetyltransferase 
p300/CBP through the LXXLL motif (38). In this study, we found that the same motif 
is important for FoxO3a suppression and resulting inhibition of apoptosis. It is likely 
that HBZ decreases histone acetylation level on Bim promoter through the interaction 
with FoxO3a and dissociation of p300/CBP from the promoter. In addition to histone 
modifications, hypermethylation of CpGs in Bim promoter was observed in some ATL 
cells. These epigenetic aberrations likely occur as the secondary changes following long 
time silencing of Bim by HBZ, although the further investigations will be required.  
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   In this study, we demonstrated that HBZ suppresses activation-induced apoptosis by 
down-regulation of pro-apoptotic genes, Bim and FasL. HBZ perturbs the function of 
FoxO3a by interaction, and induces epigenetic aberrations in the promoter region of the 
Bim gene. It has been shown that HBZ induces not only cancer but also inflammation in 
vivo. Since inflammatory diseases are essentially caused by failure to negatively 
regulate unnecessary immune responses by apoptosis, suppression of apoptosis by HBZ 
might be associated with HTLV-1-induced inflammation as well. Collectively, 
HBZ-mediated inhibition of apoptosis is likely implicated in both neoplastic and 
inflammatory diseases caused by HTLV-1.  
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Gene Fold change Gene ontology 
API5 2.18 anti-apoptosis 
BCL2L11 (Bim) -9.93 induction of apoptosis 
CARD11 2.87 regulation of apoptosis 
CASP1 2.97 apoptosis 
CD28 4.60 positive regulation of 
anti-apoptosis 
COP1 9.41 regulation of apoptosis 
DEDD2 2.01 induction of apoptosis via death 
domain receptors 
DYRK2 2.16 induction of apoptosis 
GZMB -5.90 apoptosis 
HIPK2 2.19 induction of apoptosis by 
intracellular signals 
NLRP1 3.08 induction of apoptosis 
PI3KR2 -2.68 negative regulation of 
anti-apoptosis 
PLEKHF1 2.99 induction of apoptosis 
PRDX2 -2.10 anti-apoptosis 
PRF1 3.95 virus-infected cell apoptosis 
RFFL 2.20 apoptosis 
SPHK1 -4.26 anti-apoptosis 
TNFRSF9 -2.61 induction of apoptosis 
TP53INP1 2.32 apoptosis 






Figure 1. HBZ suppresses the transcription of the Bim and FasL genes and 
consequently stimulation-induced apoptosis. A, Comparison of the Bim mRNA 
expression in the Jurkat-control, Jurkat-HBZ, CEM-control, and CEM-HBZ cells with 
or without PMA/Io stimulation by real time PCR. B, Jurkat-control and Jurkat-HBZ 
were stimulated with PMA/Io for 9h and stained with Annexin V. Percentage of 
apoptotic cells was determined by a flow cytometry. C, Jurkat-control and Jurkat-HBZ 
were treated with Fas blocking antibody for 30 min and then stimulated with PMA/Io 
for 9h. Percentages of apoptotic cells were monitored by flow cytometry. D, 
Comparison of the FasL mRNA transcription in the Jurkat-control, Jurkat-HBZ, 
CEM-control, and CEM-HBZ cells with or without PMA/Io stimulation by real time 
PCR. Error bars indicate standard deviation. Statistical differences are calculated by 
Student’s t-test. 
 
Figure 2. HBZ attenuates function of Foxo3a by physical interaction. A, Jurkat cells 
were transfected with FoxO3aAAA, a constitutively active form, expressing vector by 
using Neon with or without HBZ or its mutants. 24h after transfection, cells were 
stained with Annexin V and analyzed by a flow cytometry (n = 3). B, Jurkat cells were 
transfected with FoxO3aAAA expressing vector together with HBZ or its mutants by 
using Neon. Cells were stained with Annexin V and analyzed by flow cytometry (n = 3). 
Data are representative of three independent experiments. C, Reporter construct 
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containing the 6 x DBE and FoxO3aAAA expressing vector was transiently transfected 
with or without HBZ into Jurkat cells in the presence of Z-VAD-FMK and luciferase 
activities were measured. D, 293T cells were transfected with 6xDBE-Luc construct, 
and Flag-tagged FoxO3aAAA expression vector together with or without HBZ 
expression vector. Cells were immunoprecipitated with anti-Flag antibody and 
quantified by real-time PCR. Three independent ChIP experiments have been done and 
a representative data is shown. Error bars indicate experimental variation. E and F, The 
expression vectors of the indicated proteins were co-transfected into 293T cells, and 
their interactions were analyzed by immunoprecipitation assay. Data are representative 
of three independent experiments. Statistical differences are calculated by Student’s 
t-test. 
 
Figure 3. HBZ interferes normal localization of FoxO3a by forming ternary complex 
with FoxO3a and 14-3-3. 293FT cells were transfected with FoxO3aWT-Flag together 
with or without mycHis-HBZ. FoxO3a was detected using anti-Flag-biotin and 
secondary Streptavidin-Alexa 488 (A), and p-FoxO3a was detected using 
anti-p-FoxO3a (ser253) and secondary anti-rabbit IgG-Alexa 488 antibody (B). DAPI 
was used to counterstain the nucleus. C, 293FT cells were transfected with HA-tagged 
FoxO3aWT together with or without Flag-tagged HBZ. Cytoplasmatic and nuclear 
fraction were extracted and p-FoxO3a was detected by western-blotting. D, Endogenous 
localizations of p-FoxO3a (ser253) in HeLa and MT-1 cells were examined using 




Figure 4. Bim expression is also suppressed in ATL cell lines and ATL cases. 
Comparison of the Bim mRNA expression in non-ATL cell lines and ATL cell lines 
with or without PMA/Io stimulation (A) and in PBMCs and PHA-blasts from healthy 
donor samples and fresh ATL samples (B) by real time PCR. C, Comparison of the Bim 
mRNA expression in healthy donor sample and ATL fresh sample with or without 
PMA/Io stimulation.  
 
Figure 5. Epigenetic status of the promoter regions of the Bim gene. A- C, The 
presented diagram shows the fold difference of acetylated histone H3, acetylated 
histone H4, trimethylated H3K4, dimethylated H3K9, or trimethylated H3K27 where 
the data from Jurkat cells was arbitrarily set as 1.0. D, Quantitative ChIP assay using 
RNA polymerase II (Pol II) antibody in Jurkat, MT-1and TL-Om1 cells. E, 293T cells 
were transfected with HA-tagged FoxO3a expression vector together with or without 
HBZ expression vector. Cells were immunoprecipitated with anti-HA antibody and 
DNA binding ability at promoter 2 was quantified by real-time PCR. F, The presented 
diagram shows the fold difference of acetylated histone H3 in MT-1 cells, which were 
treated with or without 0.4 mM TSA for 15h. The data from MT-1 cells without TSA 
treatment was arbitrarily set as 1.0. G and H, MT-1 cells were treated with 0.4 mM TSA 
for 15h and Bim expression level was analyzed by qRT-PCR and flow cytometry. I, The 
presented diagram shows the fold difference of acetylated histone H3 in the Bim 
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promoter in the Jurkat-control and Jurkat-HBZ cells 9h after the stimulation with 
PMA/Io. J, HBZ transcript in shRNA transfectant of MT-1 was quantified by real-time 
PCR. K, Comparison of the Bim mRNA expression in control MT-1 cells and HBZ-KD 
MT-1 cells. Error bars indicate experimental variation. The data shown are 
representative of two or three independent experiments. Statistical differences are 
calculated by Student’s t-test. 
 
Table 1. Apoptosis-associated genes that are up- or downregulated by HBZ. A list of 
apoptosis-associated genes that were down-regulated or up-regulated (by > 2-fold) in 
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